CBDLCBD Life Sciences Inc.

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. (CBDL) is a Drug Manufacturers - Specialty & Generic company headquartered in Scottsdale, AZ, United States whose shares trade over-the-counter on the Pink tier.

CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol 'CBDL! The Company's main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector. As of 2024 company decided to rebrand and change the name from LBC to The CBD Vault . The CBD Vault Inc., is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesaling/white labeling a full line of cannabidiol based organic products including full strain of gummies, pain cream, roll on, full line of pet products, full line of cbd spa products, various strains of tinctures, cartridge, smokeables and a full pet line. The CBD Vault's products can be viewed and purchased on the company website at www.thecbdvault.com

Products and services

We are a business to ensure that most people & their pets may benefit from CBD Oil products and provide them with a healthier quality of life. Our products are made in the USA they are Industrial Hemp and 100% organic with no THC. We strive to produce the best quality products and services to provide a superior experience for our consumers within the CBD Oil community. Our goal is to be a company that sets and exceeds standards and helps the public see Cannabidiol in a new way, as a staple of healthier lifestyle.

CBDL key facts

Ticker symbol

CBDL

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Scottsdale, AZ, United States

Country of incorporation

US

Year of incorporation

2016

Employees

3

Estimated market cap

$1.39M (as of Apr 9, 2025)

Shares outstanding

3,463,971,942

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

CBD Life Sciences Inc. leadership

• Lisa Nelson — President, CEO
• Brianna Nelson — Managing Director
• Matthew McGee — CMO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with C